Global Peptide Synthesis CMO Market Growth (Status and Outlook) 2026-2032

January 2025 | 103 pages | ID: G6584F6C4233EN
LP Information

Abstracts

The global Peptide Synthesis CMO market size is predicted to grow from US$ 3437 million in 2025 to US$ 8242 million in 2032; it is expected to grow at a CAGR of 13.2% from 2026 to 2032.

Peptides, as unique drug compounds, lie between small molecules and proteins, but differ in biochemistry and therapy. They offer opportunities for therapeutic interventions that closely mimic natural pathways and play a major role in various physiological processes in the human body, including hormones and neurotransmitters, or in inflammatory responses. Peptides can be extracted naturally or synthesized artificially, and their high purity and controllable quality have made them popular drugs. Small molecule drugs rarely possess the high selectivity and rapid onset of action of peptides.

A Peptide Synthesis CMO (Contract Manufacturing Organization) is a specialized third-party manufacturer that provides custom and large-scale peptide production services for pharmaceutical, biotechnology, and research companies under contract. These organizations offer end-to-end or modular services covering peptide design support, solid-phase and liquid-phase synthesis, peptide–drug conjugate and modified peptide production, purification (e.g., preparative HPLC), lyophilization, analytical characterization, and GMP or non-GMP manufacturing according to the client’s development stage. Peptide Synthesis CMOs operate under stringent quality systems and regulatory standards, help sponsors reduce capital investment in internal manufacturing facilities, accelerate development timelines, and flexibly scale from milligram research batches to multi-kilogram commercial supply for APIs and peptide-based drug products.

The growth of the Peptide Synthesis CMO market is primarily driven by the rapid expansion of peptide therapeutics and the structural shift toward outsourcing. An increasing number of peptide drugs are being developed for metabolic disease, oncology, infectious disease and rare disorders, with more candidates entering clinical stages and requiring GMP-grade APIs and finished dosage forms. Sponsors prefer asset-light models and rely on specialized CMOs to provide end-to-end services—from route scouting and process development to large-scale manufacturing and aseptic fill–finish—so they can focus internal resources on discovery and clinical strategy. At the same time, the rising complexity of peptide molecules (long chains, cyclic and stapled structures, PEGylation, lipidation and conjugates) makes specialized equipment, advanced purification and sophisticated analytical methods indispensable, further reinforcing the role of highly capable CMOs. Integration of API and FDF capabilities, digitalization, automation, and green chemistry initiatives also act as important growth catalysts, enhancing efficiency, lowering cost of goods and aligning with big pharma’s ESG and supply chain resilience requirements.

However, the market also faces significant challenges and restraints that can slow expansion and compress margins. Peptide manufacturing is intrinsically high-cost due to expensive protected amino acids, resins and solvents, and complex purification, while large pharma and well-capitalized biotechs exert strong price pressure and often dominate contract terms. Technical risk is substantial: difficult sequences and complex modifications can lead to low yields, high scrap rates and project delays, especially for CMOs without deep scientific and analytical expertise. On top of this, increasingly stringent global regulations on impurities, nitrosamines, data integrity and GMP compliance raise the bar for quality systems and require continuous investment in equipment, IT and talent. Many players also struggle with capacity bottlenecks, dependence on a few major customers, and vulnerability to disruptions in key raw material supply. Together, these factors create a market where demand is structurally growing, but only CMOs that can manage cost, scale, regulatory complexity and technical risk simultaneously are likely to translate that demand into sustainable, profitable growth.

LPI (LP Information)' newest research report, the “Peptide Synthesis CMO Industry Forecast” looks at past sales and reviews total world Peptide Synthesis CMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Peptide Synthesis CMO sales for 2026 through 2032. With Peptide Synthesis CMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Synthesis CMO industry.

This Insight Report provides a comprehensive analysis of the global Peptide Synthesis CMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Synthesis CMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Synthesis CMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Synthesis CMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Synthesis CMO.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Synthesis CMO market by product type, application, key players and key regions and countries.

Segmentation by Type:

• APIs and Intermediates
• FDF

Segmentation by Project Stage:

• Clinical GMP
• Non-GMP
• Commercial GMP

Segmentation by Customer Type:

• Large Pharma
• Biotech Pharma
• Academic

Segmentation by Application:

• Commercial
• Academic Research
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bachem
• PolyPeptide
• USV Peptides
• Thermofischer
• Bio Basic
• JPT
• Genscript
• Medtide
• ScinoPharm
• AmbioPharm
• SN Biopharm
• CBL
• Piramal Pharma
• CordenPharma
• CPC Scientific

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peptide Synthesis CMO Market Size (2021-2032)
  2.1.2 Peptide Synthesis CMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Peptide Synthesis CMO by Country/Region (2021, 2025 & 2032)
2.2 Peptide Synthesis CMO Segment by Type
  2.2.1 APIs and Intermediates
  2.2.2 FDF
  2.2.3 Peptide Synthesis CMO Market Size by Type
    2.2.3.1 Peptide Synthesis CMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Peptide Synthesis CMO Market Size Market Share by Type (2021-2026)
2.3 Peptide Synthesis CMO Segment by Project Stage
  2.3.1 Clinical GMP
  2.3.2 Non-GMP
  2.3.3 Commercial GMP
  2.3.4 Peptide Synthesis CMO Market Size by Project Stage
    2.3.4.1 Peptide Synthesis CMO Market Size CAGR by Project Stage (2021 VS 2025 VS 2032)
    2.3.4.2 Global Peptide Synthesis CMO Market Size Market Share by Project Stage (2021-2026)
2.4 Peptide Synthesis CMO Segment by Customer Type
  2.4.1 Large Pharma
  2.4.2 Biotech Pharma
  2.4.3 Academic
  2.4.4 Peptide Synthesis CMO Market Size by Customer Type
    2.4.4.1 Peptide Synthesis CMO Market Size CAGR by Customer Type (2021 VS 2025 VS 2032)
    2.4.4.2 Global Peptide Synthesis CMO Market Size Market Share by Customer Type (2021-2026)
2.5 Peptide Synthesis CMO Segment by Application
  2.5.1 Commercial
  2.5.2 Academic Research
  2.5.3 Other
  2.5.4 Peptide Synthesis CMO Market Size by Application
    2.5.4.1 Peptide Synthesis CMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.4.2 Global Peptide Synthesis CMO Market Size Market Share by Application (2021-2026)

3 PEPTIDE SYNTHESIS CMO MARKET SIZE BY PLAYER

3.1 Peptide Synthesis CMO Market Size Market Share by Player
  3.1.1 Global Peptide Synthesis CMO Revenue by Player (2021-2026)
  3.1.2 Global Peptide Synthesis CMO Revenue Market Share by Player (2021-2026)
3.2 Global Peptide Synthesis CMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PEPTIDE SYNTHESIS CMO BY REGION

4.1 Peptide Synthesis CMO Market Size by Region (2021-2026)
4.2 Global Peptide Synthesis CMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Peptide Synthesis CMO Market Size Growth (2021-2026)
4.4 APAC Peptide Synthesis CMO Market Size Growth (2021-2026)
4.5 Europe Peptide Synthesis CMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Peptide Synthesis CMO Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Peptide Synthesis CMO Market Size by Country (2021-2026)
5.2 Americas Peptide Synthesis CMO Market Size by Type (2021-2026)
5.3 Americas Peptide Synthesis CMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Peptide Synthesis CMO Market Size by Region (2021-2026)
6.2 APAC Peptide Synthesis CMO Market Size by Type (2021-2026)
6.3 APAC Peptide Synthesis CMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Peptide Synthesis CMO Market Size by Country (2021-2026)
7.2 Europe Peptide Synthesis CMO Market Size by Type (2021-2026)
7.3 Europe Peptide Synthesis CMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peptide Synthesis CMO by Region (2021-2026)
8.2 Middle East & Africa Peptide Synthesis CMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Peptide Synthesis CMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PEPTIDE SYNTHESIS CMO MARKET FORECAST

10.1 Global Peptide Synthesis CMO Forecast by Region (2027-2032)
  10.1.1 Global Peptide Synthesis CMO Forecast by Region (2027-2032)
  10.1.2 Americas Peptide Synthesis CMO Forecast
  10.1.3 APAC Peptide Synthesis CMO Forecast
  10.1.4 Europe Peptide Synthesis CMO Forecast
  10.1.5 Middle East & Africa Peptide Synthesis CMO Forecast
10.2 Americas Peptide Synthesis CMO Forecast by Country (2027-2032)
  10.2.1 United States Market Peptide Synthesis CMO Forecast
  10.2.2 Canada Market Peptide Synthesis CMO Forecast
  10.2.3 Mexico Market Peptide Synthesis CMO Forecast
  10.2.4 Brazil Market Peptide Synthesis CMO Forecast
10.3 APAC Peptide Synthesis CMO Forecast by Region (2027-2032)
  10.3.1 China Peptide Synthesis CMO Market Forecast
  10.3.2 Japan Market Peptide Synthesis CMO Forecast
  10.3.3 Korea Market Peptide Synthesis CMO Forecast
  10.3.4 Southeast Asia Market Peptide Synthesis CMO Forecast
  10.3.5 India Market Peptide Synthesis CMO Forecast
  10.3.6 Australia Market Peptide Synthesis CMO Forecast
10.4 Europe Peptide Synthesis CMO Forecast by Country (2027-2032)
  10.4.1 Germany Market Peptide Synthesis CMO Forecast
  10.4.2 France Market Peptide Synthesis CMO Forecast
  10.4.3 UK Market Peptide Synthesis CMO Forecast
  10.4.4 Italy Market Peptide Synthesis CMO Forecast
  10.4.5 Russia Market Peptide Synthesis CMO Forecast
10.5 Middle East & Africa Peptide Synthesis CMO Forecast by Region (2027-2032)
  10.5.1 Egypt Market Peptide Synthesis CMO Forecast
  10.5.2 South Africa Market Peptide Synthesis CMO Forecast
  10.5.3 Israel Market Peptide Synthesis CMO Forecast
  10.5.4 Turkey Market Peptide Synthesis CMO Forecast
10.6 Global Peptide Synthesis CMO Forecast by Type (2027-2032)
10.7 Global Peptide Synthesis CMO Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Peptide Synthesis CMO Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bachem
  11.1.1 Bachem Company Information
  11.1.2 Bachem Peptide Synthesis CMO Product Offered
  11.1.3 Bachem Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Bachem Main Business Overview
  11.1.5 Bachem Latest Developments
11.2 PolyPeptide
  11.2.1 PolyPeptide Company Information
  11.2.2 PolyPeptide Peptide Synthesis CMO Product Offered
  11.2.3 PolyPeptide Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 PolyPeptide Main Business Overview
  11.2.5 PolyPeptide Latest Developments
11.3 USV Peptides
  11.3.1 USV Peptides Company Information
  11.3.2 USV Peptides Peptide Synthesis CMO Product Offered
  11.3.3 USV Peptides Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 USV Peptides Main Business Overview
  11.3.5 USV Peptides Latest Developments
11.4 Thermofischer
  11.4.1 Thermofischer Company Information
  11.4.2 Thermofischer Peptide Synthesis CMO Product Offered
  11.4.3 Thermofischer Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Thermofischer Main Business Overview
  11.4.5 Thermofischer Latest Developments
11.5 Bio Basic
  11.5.1 Bio Basic Company Information
  11.5.2 Bio Basic Peptide Synthesis CMO Product Offered
  11.5.3 Bio Basic Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Bio Basic Main Business Overview
  11.5.5 Bio Basic Latest Developments
11.6 JPT
  11.6.1 JPT Company Information
  11.6.2 JPT Peptide Synthesis CMO Product Offered
  11.6.3 JPT Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 JPT Main Business Overview
  11.6.5 JPT Latest Developments
11.7 Genscript
  11.7.1 Genscript Company Information
  11.7.2 Genscript Peptide Synthesis CMO Product Offered
  11.7.3 Genscript Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Genscript Main Business Overview
  11.7.5 Genscript Latest Developments
11.8 Medtide
  11.8.1 Medtide Company Information
  11.8.2 Medtide Peptide Synthesis CMO Product Offered
  11.8.3 Medtide Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Medtide Main Business Overview
  11.8.5 Medtide Latest Developments
11.9 ScinoPharm
  11.9.1 ScinoPharm Company Information
  11.9.2 ScinoPharm Peptide Synthesis CMO Product Offered
  11.9.3 ScinoPharm Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 ScinoPharm Main Business Overview
  11.9.5 ScinoPharm Latest Developments
11.10 AmbioPharm
  11.10.1 AmbioPharm Company Information
  11.10.2 AmbioPharm Peptide Synthesis CMO Product Offered
  11.10.3 AmbioPharm Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 AmbioPharm Main Business Overview
  11.10.5 AmbioPharm Latest Developments
11.11 SN Biopharm
  11.11.1 SN Biopharm Company Information
  11.11.2 SN Biopharm Peptide Synthesis CMO Product Offered
  11.11.3 SN Biopharm Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 SN Biopharm Main Business Overview
  11.11.5 SN Biopharm Latest Developments
11.12 CBL
  11.12.1 CBL Company Information
  11.12.2 CBL Peptide Synthesis CMO Product Offered
  11.12.3 CBL Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 CBL Main Business Overview
  11.12.5 CBL Latest Developments
11.13 Piramal Pharma
  11.13.1 Piramal Pharma Company Information
  11.13.2 Piramal Pharma Peptide Synthesis CMO Product Offered
  11.13.3 Piramal Pharma Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Piramal Pharma Main Business Overview
  11.13.5 Piramal Pharma Latest Developments
11.14 CordenPharma
  11.14.1 CordenPharma Company Information
  11.14.2 CordenPharma Peptide Synthesis CMO Product Offered
  11.14.3 CordenPharma Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 CordenPharma Main Business Overview
  11.14.5 CordenPharma Latest Developments
11.15 CPC Scientific
  11.15.1 CPC Scientific Company Information
  11.15.2 CPC Scientific Peptide Synthesis CMO Product Offered
  11.15.3 CPC Scientific Peptide Synthesis CMO Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 CPC Scientific Main Business Overview
  11.15.5 CPC Scientific Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Peptide Synthesis CMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Peptide Synthesis CMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of APIs and Intermediates
Table 4. Major Players of FDF
Table 5. Peptide Synthesis CMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Peptide Synthesis CMO Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Peptide Synthesis CMO Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Clinical GMP
Table 9. Major Players of Non-GMP
Table 10. Major Players of Commercial GMP
Table 11. Peptide Synthesis CMO Market Size CAGR by Project Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Peptide Synthesis CMO Market Size by Project Stage (2021-2026) & ($ millions)
Table 13. Global Peptide Synthesis CMO Market Size Market Share by Project Stage (2021-2026)
Table 14. Major Players of Large Pharma
Table 15. Major Players of Biotech Pharma
Table 16. Major Players of Academic
Table 17. Peptide Synthesis CMO Market Size CAGR by Customer Type (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Peptide Synthesis CMO Market Size by Customer Type (2021-2026) & ($ millions)
Table 19. Global Peptide Synthesis CMO Market Size Market Share by Customer Type (2021-2026)
Table 20. Peptide Synthesis CMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Peptide Synthesis CMO Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Peptide Synthesis CMO Market Size Market Share by Application (2021-2026)
Table 23. Global Peptide Synthesis CMO Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Peptide Synthesis CMO Revenue Market Share by Player (2021-2026)
Table 25. Peptide Synthesis CMO Key Players Head office and Products Offered
Table 26. Peptide Synthesis CMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Peptide Synthesis CMO Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Peptide Synthesis CMO Market Size Market Share by Region (2021-2026)
Table 31. Global Peptide Synthesis CMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Peptide Synthesis CMO Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Peptide Synthesis CMO Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Peptide Synthesis CMO Market Size Market Share by Country (2021-2026)
Table 35. Americas Peptide Synthesis CMO Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Peptide Synthesis CMO Market Size Market Share by Type (2021-2026)
Table 37. Americas Peptide Synthesis CMO Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Peptide Synthesis CMO Market Size Market Share by Application (2021-2026)
Table 39. APAC Peptide Synthesis CMO Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Peptide Synthesis CMO Market Size Market Share by Region (2021-2026)
Table 41. APAC Peptide Synthesis CMO Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Peptide Synthesis CMO Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Peptide Synthesis CMO Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Peptide Synthesis CMO Market Size Market Share by Country (2021-2026)
Table 45. Europe Peptide Synthesis CMO Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Peptide Synthesis CMO Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Peptide Synthesis CMO Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Peptide Synthesis CMO Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Peptide Synthesis CMO Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Peptide Synthesis CMO
Table 51. Key Market Challenges & Risks of Peptide Synthesis CMO
Table 52. Key Industry Trends of Peptide Synthesis CMO
Table 53. Global Peptide Synthesis CMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Peptide Synthesis CMO Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Peptide Synthesis CMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Peptide Synthesis CMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Bachem Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 58. Bachem Peptide Synthesis CMO Product Offered
Table 59. Bachem Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bachem Main Business
Table 61. Bachem Latest Developments
Table 62. PolyPeptide Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 63. PolyPeptide Peptide Synthesis CMO Product Offered
Table 64. PolyPeptide Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. PolyPeptide Main Business
Table 66. PolyPeptide Latest Developments
Table 67. USV Peptides Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 68. USV Peptides Peptide Synthesis CMO Product Offered
Table 69. USV Peptides Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. USV Peptides Main Business
Table 71. USV Peptides Latest Developments
Table 72. Thermofischer Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 73. Thermofischer Peptide Synthesis CMO Product Offered
Table 74. Thermofischer Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Thermofischer Main Business
Table 76. Thermofischer Latest Developments
Table 77. Bio Basic Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 78. Bio Basic Peptide Synthesis CMO Product Offered
Table 79. Bio Basic Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Bio Basic Main Business
Table 81. Bio Basic Latest Developments
Table 82. JPT Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 83. JPT Peptide Synthesis CMO Product Offered
Table 84. JPT Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. JPT Main Business
Table 86. JPT Latest Developments
Table 87. Genscript Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 88. Genscript Peptide Synthesis CMO Product Offered
Table 89. Genscript Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Genscript Main Business
Table 91. Genscript Latest Developments
Table 92. Medtide Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 93. Medtide Peptide Synthesis CMO Product Offered
Table 94. Medtide Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Medtide Main Business
Table 96. Medtide Latest Developments
Table 97. ScinoPharm Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 98. ScinoPharm Peptide Synthesis CMO Product Offered
Table 99. ScinoPharm Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. ScinoPharm Main Business
Table 101. ScinoPharm Latest Developments
Table 102. AmbioPharm Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 103. AmbioPharm Peptide Synthesis CMO Product Offered
Table 104. AmbioPharm Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. AmbioPharm Main Business
Table 106. AmbioPharm Latest Developments
Table 107. SN Biopharm Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 108. SN Biopharm Peptide Synthesis CMO Product Offered
Table 109. SN Biopharm Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. SN Biopharm Main Business
Table 111. SN Biopharm Latest Developments
Table 112. CBL Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 113. CBL Peptide Synthesis CMO Product Offered
Table 114. CBL Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. CBL Main Business
Table 116. CBL Latest Developments
Table 117. Piramal Pharma Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 118. Piramal Pharma Peptide Synthesis CMO Product Offered
Table 119. Piramal Pharma Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Piramal Pharma Main Business
Table 121. Piramal Pharma Latest Developments
Table 122. CordenPharma Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 123. CordenPharma Peptide Synthesis CMO Product Offered
Table 124. CordenPharma Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. CordenPharma Main Business
Table 126. CordenPharma Latest Developments
Table 127. CPC Scientific Details, Company Type, Peptide Synthesis CMO Area Served and Its Competitors
Table 128. CPC Scientific Peptide Synthesis CMO Product Offered
Table 129. CPC Scientific Peptide Synthesis CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. CPC Scientific Main Business
Table 131. CPC Scientific Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Peptide Synthesis CMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Synthesis CMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Peptide Synthesis CMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Peptide Synthesis CMO Sales Market Share by Country/Region (2025)
Figure 8. Peptide Synthesis CMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Peptide Synthesis CMO Market Size Market Share by Type in 2025
Figure 10. Global Peptide Synthesis CMO Market Size Market Share by Project Stage in 2025
Figure 11. Global Peptide Synthesis CMO Market Size Market Share by Customer Type in 2025
Figure 12. Peptide Synthesis CMO in Commercial
Figure 13. Global Peptide Synthesis CMO Market: Commercial (2021-2026) & ($ millions)
Figure 14. Peptide Synthesis CMO in Academic Research
Figure 15. Global Peptide Synthesis CMO Market: Academic Research (2021-2026) & ($ millions)
Figure 16. Peptide Synthesis CMO in Other
Figure 17. Global Peptide Synthesis CMO Market: Other (2021-2026) & ($ millions)
Figure 18. Global Peptide Synthesis CMO Market Size Market Share by Application in 2025
Figure 19. Global Peptide Synthesis CMO Revenue Market Share by Player in 2025
Figure 20. Global Peptide Synthesis CMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Peptide Synthesis CMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Peptide Synthesis CMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Peptide Synthesis CMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Peptide Synthesis CMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Peptide Synthesis CMO Value Market Share by Country in 2025
Figure 26. United States Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Peptide Synthesis CMO Market Size Market Share by Region in 2025
Figure 31. APAC Peptide Synthesis CMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Peptide Synthesis CMO Market Size Market Share by Application (2021-2026)
Figure 33. China Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Peptide Synthesis CMO Market Size Market Share by Country in 2025
Figure 40. Europe Peptide Synthesis CMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Peptide Synthesis CMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Peptide Synthesis CMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Peptide Synthesis CMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Peptide Synthesis CMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Peptide Synthesis CMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 59. United States Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 63. China Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 67. India Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 70. France Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 71. UK Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Peptide Synthesis CMO Market Size 2027-2032 ($ millions)
Figure 78. Global Peptide Synthesis CMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Peptide Synthesis CMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Peptide Synthesis CMO Market Size 2027-2032 ($ millions)